Guardant Health
GH
#1169
Rank
C$27.69 B
Marketcap
C$204.72
Share price
-0.52%
Change (1 day)
51.36%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): C-$4.86

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is C-$4.99. In 2025 the company made an earnings per share (EPS) of C-$4.73 an increase over its 2024 EPS that were of C-$5.09.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.862.76%
2025C-$4.73-7.02%
2024C-$5.09-16.82%
2023C-$6.12-33.13%
2022C-$9.1460%
2021C-$5.7255.04%
2020C-$3.69207.14%
2019C-$1.20-19.81%
2018C-$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
C-$0.36-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C-$3.50-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA